WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Patient Preferences of a Resect and Discard Paradigm

Completed

Conditions: Colonic Polyps

First Posted Date: 2014-12-02

Last Posted Date: 2017-05-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 500

Registration Number: NCT02305251

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Roux-en-Y Gastric Bypass and Weight Regain

Completed

Conditions: Obesity

Interventions: Behavioral: Eating Behavior Evaluation
Other: Measurement of Functional gastric volume
Other: Measurement of gastric pouch and GJ size

First Posted Date: 2014-11-27

Last Posted Date: 2018-04-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2

Registration Number: NCT02302898

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

Phase 2

Completed

Conditions: Soft Tissue Sarcoma
Sarcoma, Soft Tissue

Interventions: Drug: Pazopanib

First Posted Date: 2014-11-25

Last Posted Date: 2020-08-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 56

Registration Number: NCT02300545

Locations: 🇺🇸
University of Wisconsin Clinical Science Center, Madison, Wisconsin, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Mayo Clinic - Phoenix, Phoenix, Arizona, United States

and more 4 locations

Methadone in Ambulatory Surgery

Not Applicable

Completed

Conditions: Post-operative Pain
Anesthesia

Interventions: Drug: methadone
Drug: Control (Intra-operative administration of opioids, other than methadone)

First Posted Date: 2014-11-24

Last Posted Date: 2019-05-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 60

Registration Number: NCT02300077

Locations: 🇺🇸
Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer

Phase 2

Active, not recruiting

Conditions: Carcinoma, Non-Small-Cell Lung
Non-Small Cell Lung Cancer
Nonsmall Cell Lung Cancer

Interventions: Drug: Nintedanib

First Posted Date: 2014-11-24

Last Posted Date: 2024-03-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT02299141

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Asthma Symptom Based Adjustment of Inhaled Steroid Therapy in African American Children

Phase 4

Completed

Conditions: Asthma

Interventions: Other: Asthma controller medication (Beclomethasone) adjustment strategy
Other: Provider-based adjustment

First Posted Date: 2014-11-21

Last Posted Date: 2018-10-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 206

Registration Number: NCT02298205

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Phase 2

Active, not recruiting

Conditions: Squamous Cell Carcinoma of the Head and Neck
Squamous Cell Carcinoma, Head and Neck
Cancer of Head and Neck
Head and Neck Cancer
Carcinoma, Squamous Cell of Head and Neck
Neoplasms, Head and Neck

Interventions: Biological: MK-3475 (neoadjuvant)
Procedure: Surgery
Radiation: Intensity modulated radiation therapy
Radiation: Image-guided radiation therapy
Drug: Cisplatin
Biological: MK-3475 (adjuvant)
Procedure: Peripheral blood

First Posted Date: 2014-11-20

Last Posted Date: 2024-04-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 67

Registration Number: NCT02296684

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers

Phase 2

Withdrawn

Conditions: Esophagogastric Cancer

Interventions: Drug: Pemetrexed
Drug: Oxaliplatin
Genetic: Germline genotyping analyses for TSER
Drug: Leucovorin
Drug: Fluorouracil

First Posted Date: 2014-11-20

Last Posted Date: 2016-03-08

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT02296671

Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer

Phase 1

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: nab-Paclitaxel
Drug: Gemcitabine
Radiation: Intensity modulated radiation

First Posted Date: 2014-11-05

Last Posted Date: 2019-06-19

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT02283372

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer

Phase 2

Terminated

Conditions: Colorectal Cancer

Interventions: Drug: Pacritinib

First Posted Date: 2014-10-28

Last Posted Date: 2017-05-01

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 11

Registration Number: NCT02277093

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy